Literature DB >> 7373289

Supersensitivity of dopamine-autoreceptors. The effect of gammabutyrolactone in long-term haloperidol treated rats.

G Stock, J Steinbrenner, P Kummer.   

Abstract

Rats were injected daily with haloperidol, 0.5 mg/kg i.p. for a period of 16 days. 24 hours after the last injection of haloperidol these rats were challenged with gammabutyrolactone in doses of 200-750 mg/kg i.p. The ensuing increase in neostriatal dopa-accumulation was significantly lower than in rats not previously treated with haloperidol. Since the increase in dopa-accumulation following GBL-treatment is most probably independent of postsynaptically located DA-receptors the difference between the experimental series is explained in terms of reduced feedback activation of DA-synthesis due to the increased sensitivity of presynaptically located DA-autoreceptors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7373289     DOI: 10.1007/bf01670165

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  15 in total

1.  The effect of long-term penfluridol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens and in the corpus striatum.

Authors:  D M Jackson; N E Andén; J Engel; S Liljequist
Journal:  Psychopharmacologia       Date:  1975-12-31

2.  Acute and subacute effects of neuroleptics dopamine synthesis and release in the rat striatum.

Authors:  B Scatton; C Garret; L Julou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity.

Authors:  W Kehr; A Carlsson; M Lindqvist; T Magnusson; C Atack
Journal:  J Pharm Pharmacol       Date:  1972-09       Impact factor: 3.765

4.  Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow.

Authors:  G Stock; T Magnusson; N E Andén
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Isolated removal of hypothalamic or other brain nuclei of the rat.

Authors:  M Palkovits
Journal:  Brain Res       Date:  1973-09-14       Impact factor: 3.252

6.  Enhancement of methylphenidate-induced stereotypies by repeated administration of neuroleptis.

Authors:  B Fjalland; I Moller Nielsen
Journal:  Psychopharmacologia       Date:  1974-01-11

7.  Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range.

Authors:  S Udenfriend; S Stein; P Böhlen; W Dairman; W Leimgruber; M Weigele
Journal:  Science       Date:  1972-11-24       Impact factor: 47.728

8.  Presynaptic dopamine receptors. Development of supersensitivity following treatment with fluphenazine decanoate.

Authors:  M C Nowycky; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

9.  Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.

Authors:  A C Sayers; H R Bürki; W Ruch; H Asper
Journal:  Psychopharmacologia       Date:  1975

10.  A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain.

Authors:  W Kehr; A Carlsson; M Lindqvist
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

View more
  3 in total

1.  Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.

Authors:  Taleen Der-Ghazarian; Sergios Charntikov; Fausto A Varela; Cynthia A Crawford; Sanders A McDougall
Journal:  J Neural Transm (Vienna)       Date:  2010-04-06       Impact factor: 3.575

2.  Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.

Authors:  M Toru; N Mataga; M Takashima; T Nishikawa
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

3.  Chronic L-dopa treatment of rats and mice does not change the sensitivity of post-synaptic dopamine receptors.

Authors:  D M Jackson; O F Jenkins; R Malor; M J Christie; P Gregory
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.